Stimulant Effects on Disruptive Behavior

Recruiting Phase 4 Interventional Study
Attention Deficit Hyperactivity Disorder Problem Behavior
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Prior Safety Data This treatment has already been tested in at least one earlier human trial. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
48 Months – 12
Sex
Any
Trial phase
Phase 4
Study type
Interventional
Purpose
Treatment
Participants needed
10 (estimated)
Sponsor
Matthew J O'Brien, PhD, BCBA-D · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goal of this study is to determine the effects of stimulant medication on disruptive behavior, function, preference and choice; however, it is primarily methodological and will add to current research by establishing an effective evaluation of the impact of stimulant medication on these behaviors. Three behavior assessments for children and adolescents diagnosed with AD/HD who exhibit disrupti…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Participant must be a child or adolescent between the ages of 4 years, 0 months, and 13 years, 0 months (participants must not be older than 12 years, 11 months). 2. Participant must have a valid diagnosis of attention deficit/hyperactivity disorder (AD/HD). No specification …
Contacts

Matthew J O'Brien, PhD

319.384.9827

matthew-j-obrien@uiowa.edu

CONTACT